LIVE Webinar

Scaling AI In Life Sciences:Unlocking Enterprise-wide Value

From AI Pilots to Production

Oct 10, 2025 | Friday
10:30 AM - 11:15 AM EST

Do you think you've hit a home run with high AI model accuracy? Think again! According to a recent MIT report, 95% of GenAI projects fail to deliver measurable impact. It's not because the models lack power—it's because organizations aren't designing their implementations effectively.

Today, life sciences leaders face a critical choice: succumb to "shiny object syndrome" with fleeting pilots, or integrate AI deeply into the operational core of R&D, clinical care, manufacturing, and field services to unlock lasting value.

This webinar reveals how to get it right and transform GenAI into a powerful engine for Pharma, Biopharma, MedTech, and Digital Health. Discover strategies to embed intelligence into systems, workflows, and governance. See real-world examples of accelerated regulatory cycles, safer clinical decisions, and consistent cost reductions across labs and supply chains. Learn to balance robust technical guardrails with practical change management, empowering you to scale with confidence instead of caution.

Attend Our Webinar To Explore

Why a platform-first architecture outpaces one-off tools by enabling cross-functional context, persistent memory, and composable automation that turn isolated pilots into enterprise assets.

Concrete governance patterns such as tiered controls, auditable context stores, and risk triggers that let users drive agentic automation in clinical, manufacturing, and field settings safely.

Change and talent actions that stick, including practical steps to redeploy people into AI-augmented roles, upskill domain experts to validate outputs, and amplify the “shadow AI” workflows.

The right executive KPIs to measure agility, care quality, and adaptive operational impact and link pilots to P&L drivers like reduced outsourcing and faster time-to-market.

How to design “learning loops” – both technical and human, with more stringent workflows (EHR/LIMS/CTMS) and zero compliance gaps.

When to buy, when to co-develop, and how to negotiate portability, SLAs, and escape clauses to avoid costly lock-in.

Featuring Insights From

Our Speakers

Co-hosted with industry experts

Ramji P Vasudevan
BU Head - Life Sciences Altimetrik

Makarand Kulkarni
Head GCC
Opella

Nicholas Balestrino
Director - AI & Innovation
Novartis

Altimetrik is a Major Contender in the Everest PEAK
Matrix® Assessment 2025 for AI-first innovation across
the life sciences value chain. Want to know more?

Altimetrik in Life Sciences

100% Value Chain Digitization

Full-stack digital capabilities across R&D, clinical,
and commercial

3 Cloud Partnerships

Major hyperscalers: AWS, Azure, GCP for scalable life sciences IP

5+ Tech Integrations

Key platforms integrated: Veeva, Medidata,
Salesforce, Oracle

2X Decision Agility

Faster decisions through AI/ML-powered insights

Strong Market Reach

Deep presence with long-standing life sciences clients worldwide

Turn Experiments into Tangible Breakthroughs

Gain deep insights and a simple, step-by-step playbook to go live in production and keep delivering real impact.